Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | +2.26% | +5.65% | +68.63% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.63% | 11.95M | |
+9.92% | 115B | |
+12.03% | 106B | |
-2.59% | 21.96B | |
-12.52% | 21.87B | |
-5.29% | 19.21B | |
-3.84% | 18.08B | |
-38.57% | 17.71B | |
+7.19% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Upgrades Chemomab Therapeutics to Outperform